abstract |
The present invention provides N-1-benzyl-2-hydroxy-3- (hetero) arylamino-propyl-isophthalamide of formula (I) having BACE2 inhibitory activity, and use thereof as therapeutically active substance, preparation thereof and its The pharmaceutical composition relates to: (I) The active compounds of the invention are useful, for example, in the treatment and / or prevention of type 2 diabetes. |